Published Version
Open DOI LinkAbstract
This case series describes the different dermatologic adverse events that patients experienced while using amivantamab.
Full Text
Open DOI Link
Sign-in/Register to access full text options Topics from this Paper
Dermatologic Adverse Events- Case Series
- Adverse Events
Create a personalized feed of these topics
Get StartedTalk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
Dermatologic Adverse Events in Acute Lymphocytic Leukemia Patients Treated with Bispecific T-Cell Engager Blinatumomab 
Relevant
Not Relevant
Blood
Nov 15, 2022
RelevantNot Relevant 1261 Patterns of dermatological and other immune related adverse events as a signal for survival RelevantNot Relevant
- Journal for ImmunoTherapy of Cancer
- Oct 31, 2023
RelevantNot Relevant Management of dermatologic adverse events associated with tumor treating fields in patients with glioblastoma multiforme: A 27-case series. RelevantNot Relevant
- Asia-Pacific journal of oncology nursing
- Aug 1, 2022
RelevantNot Relevant Management of dermatologic adverse events associated with tumor treating fields in patients with glioblastoma multiforme: A 27-case series RelevantNot Relevant
- Asia-Pacific Journal of Oncology Nursing
- Aug 1, 2022
RelevantNot Relevant Characteristics and management of tumor treating fields-related dermatological complications in patients with glioblastoma. RelevantNot Relevant
- Medicine
- May 19, 2023
RelevantNot Relevant AB0283 Dermatologic adverse events in a cohort of patients with rheumatoid arthritis using anti-tnf therapy in a real-life setting RelevantNot Relevant
- Annals of the Rheumatic Diseases
- Jun 1, 2013
RelevantNot Relevant AB0407 Dermatologic Adverse Events in A Cohort of Patients with Rheumatoid Arthritis Using Anti-TNFs in A Real-Life Setting RelevantNot Relevant
- Annals of the Rheumatic Diseases
- Jun 1, 2014
RelevantNot Relevant Biological therapy in Psoriasis: An emphasis on its dermatologic adverse events. RelevantNot Relevant
- Asian Pacific journal of allergy and immunology
- Jan 1, 2021
RelevantNot Relevant Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor. RelevantNot Relevant
- European journal of cancer (Oxford, England : 1990)
- Apr 1, 2016
RelevantNot Relevant Dermatologic adverse events of Bcr-Abl tyrosine kinase inhibitors RelevantNot Relevant
- Russian journal of hematology and transfusiology
- May 21, 2020
RelevantNot Relevant FRI0112 Dermatologic Adverse Events in a Cohort of Patients with Rheumatoid Arthritis Using Biological Therapy in a Real-Life Setting RelevantNot Relevant
- Annals of the Rheumatic Diseases
- Jun 1, 2015
RelevantNot Relevant Predictive factors for adverse dermatological events during pegylated/interferon alpha and ribavirin treatment for hepatitis C RelevantNot Relevant
- Journal of Clinical Virology
- Jul 1, 2014
RelevantNot Relevant Managing The Skin Toxicities From New Melanoma Drugs RelevantNot Relevant
- Current Treatment Options in Oncology
- May 28, 2014
RelevantNot RelevantREAD MORE FROMJAMA Dermatology
Rituximab and Omalizumab Combination Therapy for Bullous Pemphigoid RelevantNot Relevant
- JAMA Dermatology
- Nov 22, 2023
RelevantNot Relevant Evaluation of DermSat-7 for Assessing Treatment Satisfaction in Patients with Acne RelevantNot Relevant
- JAMA Dermatology
- Nov 22, 2023
RelevantNot Relevant Management of Adult Patients With Drug Reaction With Eosinophilia and Systemic Symptoms RelevantNot Relevant
- JAMA Dermatology
- Nov 15, 2023
RelevantNot Relevant Rapid Improvement in Recalcitrant Cutaneous Juvenile Dermatomyositis With Anifrolumab Treatment 
Open AccessRelevantNot Relevant
Open Access- JAMA Dermatology
- Nov 11, 2023
RelevantNot Relevant Skin Cancers in Medicare Beneficiaries With Actinic Keratoses RelevantNot Relevant
- JAMA Dermatology
- Nov 8, 2023
RelevantNot Relevant Pathologist Characteristics Associated With Rendering Higher-Grade Diagnoses for Melanocytic Lesions RelevantNot Relevant
- JAMA Dermatology
- Nov 8, 2023
RelevantNot Relevant